Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 51655-849

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 51655-849). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 849 26 Rev A 02 23)

Label (51655 849 26   Rev A 02 23)
Label for Venlafaxine Hydrochloride Extended-Release Capsules USP 75 mg, containing 90 capsules. The prescription drug label includes storage instructions at 20°-25°C, manufacturer Northwind Pharmaceuticals, and packaging information. It is marked Rx Only with NDC 51655-849-26.*
FDA Label Image

Figure (Venlafaxine Fig1)

Figure (Venlafaxine Fig1)
A scatter plot chart illustrating pharmacokinetic (PK) changes of venlafaxine and its metabolite ODV under various special population conditions, including hepatic impairment, renal impairment, CYP2D6 polymorphism, age over 60, and gender differences. The x-axis represents fold change relative to the reference value, and PK parameters shown include Cmax and AUC with 90% confidence intervals.*
FDA Label Image

Figure (Venlafaxine Fig2)

Figure (Venlafaxine Fig2)
A scatter plot chart showing the fold change with 90% confidence intervals for pharmacokinetic parameters (Cmax, AUC) of venlafaxine in the presence of various interacting drugs including Ethanol, Diazepam, Cimetidine, Ketoconazole (in CYP2D6 extensive and poor metabolizers), Indinavir, Metoprolol, Imipramine, and Lithium. The x-axis represents change relative to a reference value.*
FDA Label Image

Figure (Venlafaxine Fig3)

Figure (Venlafaxine Fig3)
A graph displaying fold change and 90% confidence intervals for various interacting drugs, analytes, and their pharmacokinetic parameters (Cmax and AUC), relative to a reference value. The x-axis shows fold change ranging approximately from 0 to 3, with different drugs like Ethanol, Diazepam, Alprazolam, Indinavir, Metoprolol, Risperidone, Imipramine, Haloperidol, Caffeine, Tolbutamide, and Lithium listed on the y-axis along with their measured analytes.*
FDA Label Image

Chemical Structure (Venlafaxine Str)

Chemical Structure (Venlafaxine Str)
Chemical structure of venlafaxine hydrochloride is depicted in the image, illustrating its molecular framework including a methoxyphenyl group, cyclohexanol moiety, and dimethylaminoethyl side chain along with the hydrochloride salt.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.